Evidence map›Paper›PMID 38786178›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Potential Surviving Effect of

Jawaher Alqahtani, Walaa A Negm, Engy Elekhnawy, Ismail A Hussein, Hassan Samy Hassan, Abdullah R Alanzi, Ehssan Moglad, Rehab Ahmed, Sarah Ibrahim, Suzy A El-Sherbeni

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Active Components ofAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jawaher AlqahtaniDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.ORCID 0000-0002-3640-9612
Walaa A NegmDepartment of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.ORCID 0000-0003-0463-8047
Engy ElekhnawyDepartment of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.ORCID 0000-0001-8287-1026
Ismail A HusseinDepartment of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt.ORCID 0000-0001-6033-7359
Hassan Samy HassanFaculty of Pharmacy, Tanta University, Tanta 31527, Egypt.ORCID 0009-0009-6504-0533
Abdullah R AlanziDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.ORCID 0009-0000-2565-6573
Ehssan MogladDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam bin Abdulaziz University, P.O. Box 173, Alkharj 11942, Saudi Arabia.
Rehab AhmedDepartment of Natural Products and Alternative Medicine, Faculty of Pharmacy, University of Tabuk, Tabuk 47713, Saudi Arabia.ORCID 0000-0003-2476-469X
Sarah IbrahimHuman Anatomy and Embryology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
Suzy A El-SherbeniDepartment of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.ORCID 0000-0001-9031-0149

Funding

Wellcome Trust 202434
6 · The paper itself

Abstract

The increasing rates of morbidity and mortality owing to bacterial infections, particularly

Indexed as

antibiotic resistancebiofilminflammatory markersLC-ESI-MS/MSqRT-PCRsystemic infection

Identifiers

PMID38786178
PMCPMC11118852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.